Traduction de «poste breveté » (Français → Anglais) :

(Return tabled) Question No. 969 Mr. Ted Hsu: With regard to National Research Council Canada (NRC): (a) what is the department responsible for collecting royalties for patents licensed by NRC; (b) what is the breakdown, in dollars, of billing for royalties for patents licensed by NRC, by month from January, 2010 to the present; (c) what is the amount, in dollars, received by NRC from collecting royalties for patents they have licensed, by month from January, 2010 to the present; (d) what is the amount of outstanding royalties for patents licensed by NRC payable to NRC as of September 21, 2012; (e) how many outstanding bills, pertaining to royalties for patents licensed by NRC that are owed to NRC, have not been issued since January, 20 ...[+++]10, by month, and what are each of their dollar amounts; (f) what is the total, in dollars, of outstanding royalties for patents licensed by NRC owed to NRC since January, 2010, by month; (g) where are royalties received for patents licensed by NRC allocated; and (h) which line items in the NRC budget receive how many dollars?

Question No. 609 Ms. Anne Minh-Thu Quach: With respect to drug regulation and approval: (a) does the 2012 Economic Action Plan provide for decreases or increases in the financial and human resources allocated to (i) drug approval services, (ii) regulatory activities to evaluate and monitor the safety, efficacy and quality of drugs before and after they enter the marketplace, (iii) activities related to the review of submissions by drug manufacturers for market authorization and post-market changes, (iv) activities related to enforcing compliance with existing regulations, including those concerning clinical trials, drug manufacturing and the reporting of adverse drug reactions, (v) activities of the Patented Medicine Prices Review Board, (v ...[+++]i) services such as the Patent Register, Drug Product Database, Notice of Compliance, and Progressive Licensing Project, (vii) various areas of Health Canada such as the Marketed Health Products Directorate, Therapeutic Products Directorate, Biologics and Genetic Therapies Directorate, and the Veterinary Drugs Directorate; (b) for each of the programs and directorates listed in (a), (i) what is the estimated extent of the decreases or increases in human or financial resources, (ii) are positions expected to be cut and, if so, how many will be eliminated; (c) was a value-for-money assessment conducted for the drug approval process; and (d) what is the government’s financial allocation plan regarding drug regulation?

In the same year, one additional legal secretary for the Advocate General for review proceedings seems necessary as the judgments of the Court of First Instance on appeal against decisions of the Community Patent Court will have reached a number where their scrutiny in view of possible review proceedings justifies an additional post.

In the country I know best, SMEs account for 20% of all patents, 40% of all gross investment, 49% of total turnover, 70% of all workers and 80% of all trainees.

We have to remember that the decisions that are now required concerning European patents, the liberalisation of competition among the gas and electricity boards and in the Post Office, making air traffic more flexible, Galileo, and other matters, will not result in any real changes until four to ten years have gone by after the political decision is taken.

I believe that the European patent is an important step along this road. We also need to move more quickly in liberalising telecommunications, energy and the postal services, if we want to get closer to these goals.